west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "胸腔积液" 61 results
  • Dignosis and Management of Parapneumonic Effusions in 97 Cases

    Objective To elucidate the clinical features and treatment of parapneumonic effusions ( PPE) . Methods Ninety-seven patients were analyzed retrospectively in Guangzhou First Municipal People’s Hospital fromJanuary 2004 to July 2008. The data of 54 patients with complicated parapneumonic effusion ( CPPE) and 9 cases with empyema were compared with 49 patients with tuberculosis pleural effusions. Results Of 97 cases, 34 patients with uncomplicated parapneumonic effusion ( UPPE) were treated with antibiotics only, whose hospitalization time was ( 14. 8 ±7. 6) days, and 27 cases were cured ( 79. 4% ) . Of 54 CPPE patients, 42 were treated with antibiotics and pleural space drainage with central venous catheter, whose hospitalization time was ( 21. 7 ±13. 0) days, and 32 were cured ( 76. 2% ) . Another12 CPPE patients were treated with interapleural urokinase and drainage from the chest tube, whose hospitalization time was ( 22. 5 ±9. 3) days, and 8 were cured ( 66. 7% ) . Nine cases with empyema were rinsed the pleural with metronidazole solution, whose hospitalization time was ( 25. 7 ±17. 4) days, and 8 were cured( 89. 0% ) . Compared with the tuberculous pleurisy patients, most CPPE and empyema occurred in middle and old aged patients with an average age of ( 63. 3 ±19. 3) years. Polykaryocyte and lactate dehydrogenase increased significantly. Adenosine deaminase ( ADA) was lt; 45 U/L in most UPPE and empyema patients, but was gt; 45 U/L in 7 cases ( 11% ) . Conclusions UPPE is simple and preferably treated with antibiotics alone. While CPPE and empyema should be drainaged as early as possible, and the low-dose urokinase may be helpful. The level of ADA can not absolutely distinguish parapneumonic effusion from tuberculous pleural effusion.

    Release date:2016-09-14 11:25 Export PDF Favorites Scan
  • 微创胸膜腔置管注入尿激酶治疗结核性胸腔积液

    【摘要】 目的 探讨微创胸膜腔置入中心静脉导管(简称导管)注入尿激酶治疗结核性包裹性胸腔积液(简称积液)的临床价值。方法 2008年6月-2009年8月在正规抗结核治疗基础上,选取确诊积液患者72例,按数字随机法分为治疗组和对照组,治疗组36例经超声引导导管置入胸膜腔并注入生理盐水50 mL加尿激酶10万 U,对照组36例多次穿刺抽液,比较两组疗效及积液引流量、胸膜厚度、积液吸收时间等。结果 治疗组28例显效,5例好转,3例无效;对照组10例显效,13例好转,13例无效,两组疗效差异具有统计学意义(Plt;0.05)。治疗组与对照组平均积液引流量分别为1 421 mL和756 mL,胸膜厚度分别为(1.9±0.4) mm和(3.7±1.2) mm,积液吸收时间分别为(13.3±1.2)d和(17.3±1.6)d,两组间比较差异均有统计学意义(Plt;0.05)。结论 超声引导导管置入胸膜腔并注入尿激酶治疗结核性包裹性胸腔积液疗效显著,可增加引流量,减轻胸膜肥厚,改善肺功能,减少穿刺机会。

    Release date:2016-09-08 09:31 Export PDF Favorites Scan
  • The Value of Pleural Biopsy in the Etiological Diagnosis of Pleural Effussion

    目的:探讨胸膜活检对胸腔积液病因诊断的价值。方法:对268例胸腔积液患者行经胸壁胸膜活检术。结果:268例患者共行胸膜活检289次,二次及以上活检者19例,获取胸膜组织244例,穿刺成功率91%,经病理检查有18例为正常胸膜组织,阳性诊断者为226例,阳性率92.6%(226/244),其病理诊断为结核104例(46%)、肿瘤54例(23.9%)、慢性炎症68例(30.1%);发生并发症者19(6.6%),全部为气胸,肺压缩均小于30%,未做特殊处理数日后自行吸收。结论:从本组资料可以看出,经胸壁胸膜活检术对于胸腔积液的病因诊断具有非常好的效果,相比胸水涂片或病理检查具有更高的阳性率。因此经胸壁胸膜活检术由于它的简单、安全、高效等特点,目前在胸腔积液病因诊断方面仍是一项重要的手段。

    Release date:2016-09-08 10:14 Export PDF Favorites Scan
  • The Differential Diagnostic Value of Major Fibrinolytic Parameters in Pleural Fluid

    【Abstract】Objective To explore the differential diagnostic value of major fibrinolytic parameters in pleural fluid. Methods Tissue-type plasminogen activator( t-PA) and plasminogen activator inhibitor-1( PAI-1) in pleural fluid at the first thoracentesis were measured with ELISA and D-dimer was measured with immunoturbidimetry. Results Eighty-four patients with pleural effusion were enrolled, among which 40 with malignant effusion, 33 with infectious effusion and 11 with transudative effusion. t-PA level was higher in malignant and transudative pleural fluid than that in infectious pleural fluid[ ( 52. 49 ±31. 46) ng /mL and ( 58. 12 ±23. 14) ng /mL vs ( 37. 39 ±22. 44) ng /mL, P lt; 0. 05] , but was not statistically different between malignant pleural fluid and transudative ( P gt; 0. 05) . PAI-1 level was higher in malignant and infectious pleural fluid than that in transudative [ ( 164. 86 ±150. 22) ng/mL and ( 232. 42 ±175. 77) ng/mL vs ( 46. 38 ±16. 13) ng/mL, P lt; 0. 01] , but was not statistically different between malignant and infectious pleural fluid( P gt;0. 05) . D-dimer levels in the three types of pleural fluid were significantly different, which was ( 23. 66 ±25. 18) mg/L, ( 6. 36 ±10. 87) mg/L and ( 66. 90 ±42. 17) mg/L in malignant, transudative and infectious pleural fluid, respectively. As single-item detection for malignant pleural fluid, the cutoff of t-PA was gt; 38. 7 ng/mL( area under ROC curve was 64. 0 ) , with sensitivity of 60. 0% , specificity of 63. 6%, positive predictive value of 66. 7%, negative predictive value of 56. 8% and accuracy of 61. 6% .The cutoff of D-dimer was lt; 27. 0 mg/L( area under ROC curve was 85. 5) , with sensitivity of 84. 8% ,specificity of 72. 5% , positive predictive value of 85. 3% , negative predictive value of 71. 8% and accuracy of78.1%. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of combined examination( t-PA + D-dimer) were 92. 5% , 60. 6% , 74. 0% , 87. 0% , 78. 1% , respectively.Conclusions The t-PA, PAI-1 and D-dimer levels are significantly different in the three types of pleural fluid. The detection of fibrinolytic parameters in pleural fluid, especially the value of D-dimer,may be helpful in the differential diagnosis of pleural effusion.

    Release date:2016-09-14 11:23 Export PDF Favorites Scan
  • Clinical Analysis of Therapeutic Video-mediastinoscopy for Thoracic Disease

    Objective To assess clinical outcomes of therapeutic video-mediastinoscopy (VMS). Methods Clinical data of 82 patients undergoing VMS in Zhongshan Hospital of Dalian University from December 2008 to October 2011 were retrospectively analyzed. Among them,24 patients received therapeutic VMS,including 18 men and 6 women with their median age of 56 (22-81) years. Three patients underwent operation through a neck incision,4 patients through a parasternal incision,and 17 patients through a lateral intercostal incision. Five patients received local anesthesia and basal anesthesia,and all the other patients received general anesthesia through single-lumen or double-lumen endotracheal intubation. Results Twelve patients with pleural effusion underwent pleural or lung biopsy and talc pleurodesis. Pathology examination showed malignant diseases in 11 patients and tuberculous pleural effusion in 1 patient. The median operation time was 35 (30-50) minutes,and postoperative hospital stay was 3-6 days. These patients were followed up for 1 month without recurrence of pleural effusion. Ten patients with mediastinal mass received pathological diagnosis and complete mass resection with their median operation time of 55 (30-270) minutes and median hospital stay of 7 (5-40) days. Two patients with hyperhidrosis underwent bilateral intercostal VMS sympathectomy. Their operation time was 60 minutes and 50 minutes respectively,and their hospital stay was 3 days. Postoperatively their sweating symptoms obviously resolved. They were followed up for 3 months,and their hands,feet and armpit were warm and dry. There was no in-hospital death in this group. Two patients (8.3%) had postoperative complications including 1 patient with phrenic nerve injury and another patient with pneumonia. Opioid analgesic drugs were not used postoperatively in 9 patients. Conclusion Therapeutic VMS is a safe,effective,minimally invasive and cosmetic procedure,but it is not suitable for resection of a large mediastinal mass.

    Release date:2016-08-30 05:46 Export PDF Favorites Scan
  • 纤维支气管镜代胸腔镜诊断不明原因胸腔积液28例临床分析

    目的探讨纤维支气管镜代胸腔镜检查在诊断胸腔积液中的临床应用价值。 方法以我院2013年5月至2014年8月收治的不明原因胸腔积液患者28例为研究对象, 对其行纤维支气管镜代胸腔镜检查, 获取胸腔积液及病变组织行病理学检查。 结果28例患者中, 2例脓胸患者未行病理检查, 其余26例患者均行病理检查并明确诊断, 确诊率为92.86%。其中, 18例为恶性肿瘤病变, 包括腺癌10例, 鳞癌8例; 8例为肉芽肿样改变, 诊断为结核性胸腔积液, 经正规抗结核治疗胸腔积液消失。27例患者的人工气胸在术后1~3 d内完全吸收拔管, 无术中术后大出血、伤口感染以及胸腔积液新发感染等并发症发生。 结论纤维支气管镜代胸腔镜在检查胸腔积液病因中是一种安全有效、检出率高的检查方法, 值得临床大范围应用与推广。

    Release date: Export PDF Favorites Scan
  • Analysis of 54 Cases Suffering from Transudatory Hydrothorax

    目的:为了提高漏出性胸腔积液的诊断率对其进行病因分析。方法:对54 例漏出性胸腔积液病例就不同年龄及病变部位进行分析。结果:50 岁以下以肾病综合征居首位;50~ 60岁以岁慢性肺源性心脏病右心衰竭及肝硬化为主;60 岁以上岁以慢性肺源性心脏病右心衰竭居发病之首,其次为冠状动脉粥样硬化性心脏病。左侧以心包积液为主。右侧以慢性肺源性心脏病右心衰竭居发病之首,其次为冠状动脉粥样硬化性心脏病,肝硬化居第三。双侧以慢性肺源性心脏病右心衰竭居首位,其次为肾病综合征,高血压心脏病居第三。结论:漏出性胸腔积液的发病年龄,病变部位不同病因各异。

    Release date:2016-09-08 10:00 Export PDF Favorites Scan
  • 临床病理讨论———口眼干、胸腔积液、右下肢疼痛

    Release date:2016-08-30 11:53 Export PDF Favorites Scan
  • 电视胸腔镜手术治疗恶性胸腔积液37例临床分析

    目的探讨电视胸腔镜手术治疗恶性胸腔积液的方法,总结其临床经验。 方法回顾性分析2009年1月至2011年12月宝鸡市中心医院37例恶性胸腔积液患者的临床资料, 男21例、女16例, 年龄43~75岁。其中肺癌15例,乳腺癌7例,食管癌7例,胃癌4例,胸膜间皮瘤3例,卵巢癌1例;均为单侧胸腔积液,其中左侧胸腔积液22例, 右侧胸腔积液15例。所有患者均行电视胸腔镜手术(VATS)或VATS辅助小切口完成手术,在电视胸腔镜下行胸膜剥脱术,并喷洒滑石粉固定胸膜。 结果围术期无死亡,7例(18.9%)延长切口,手术时间(40.32±19.06)min,术中出血量(90.09±41.03)ml,术后(7.31±2.08)d拔除胸腔引流管,术后住院时间(9.02±3.11)d。手术有效率100%,其中完全缓解19例(51.4%)。术后出现轻度并发症,如肺部感染、持续性漏气和切口感染等, 经对症处理治愈。 结论电视胸腔镜治疗恶性胸腔积液是一种微创、有效、实用的治疗方法。

    Release date: Export PDF Favorites Scan
  • 隧道式胸腔引流管在恶性胸腔积液患者中的应用

    摘要: 目的 介绍隧道式胸腔引流管(tunnelled pleural catheter,TPC)治疗恶性胸腔积液(MPE)的方法,探讨其临床应用价值。 方法 分析美国西南医学中心St.Paul医院自2002年10月至2005年11月共对112例MPE患者植入TPC的临床资料,其中男69例,女43例;年龄58.5±6.7岁。主要原发病为原发性肺癌、转移性肺肿瘤(原发癌为淋巴瘤、乳腺癌、卵巢癌)、胸膜间皮瘤;分析MPE患者TPC植入的效果。 结果 在3年观察期内,112例MPE患者共应用125例次TPC治疗,其中10例为对侧植入TPC,4例为同侧再次植入TPC。随访2周后有48例次症状完全缓解,62例次症状部分缓解,5例次症状未缓解,有5例次植管失败,5例次TPC植入术后2周内失去随访。 120例次成功植入TPC患者中有51例发生继发性胸膜炎,仅5例在管道拔除后需要再次胸腔治疗。随访2周中单胸腔积液量lt;20%。导管留置时间平均为56 d。所有TPC植入术后患者随访期的生存时间平均为144 d,随访1个月和1年的病死率分别为128%和836%。 结论 对具有门诊治疗条件、需要姑息治疗的MPE患者,TPC是有效的方法之一。

    Release date:2016-08-30 06:03 Export PDF Favorites Scan
7 pages Previous 1 2 3 ... 7 Next

Format

Content